• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Integra NeuroSciences PR AccuDrain with Anti-Reflux Valve; External CSF Drainage

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Integra NeuroSciences PR AccuDrain with Anti-Reflux Valve; External CSF Drainage Back to Search Results
Catalog Number INS8401
Medical Device Problem Codes Crack (1135); Fluid/Blood Leak (1250)
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 07/17/2026
Type of Reportable Event Serious Injury
Event or Problem Description
N/a.
 
Event or Problem Description
A facility reported that the accudrain device (catlog# unknown) was used on a patient to drain csf, and the port closest to the head with the yellow cap was leaking; when they attempted to remove the cap, it cracked off.It was reported that there was no injury to the patient, but infection was noted.Additional information regarding the type of infection and any required intervention has been requested.
 
Additional Manufacturer Narrative
Updated fields: d1, d2a, d4, d9, g3, g6, h2, h3, h4, h6, h11.The accudrain with anti-reflux valve (ins8401) was returned for evaluation: device history record (dhr) - the dhr was reviewed and shows no abnormalities that could be associated with the reported condition.Failure analysis - a segment of the patient line proximal to the patient, a red cap, a yellow cap, and a green (non-integra) cap were returned for evaluation.Because the leak was reported at the "port closest to the head with the yellow cap," the yellow cap was visually inspected and no cracks or defects were observed.However, evaluation of the patient-line stopcock revealed cracks on the side and bottom of the stopcock body.Additionally, the port to which the yellow cap had been attached was found broken off and remained attached to the yellow cap.The stopcock also exhibited a whitish, opaque appearance, which is characteristic of exposure to an incompatible chemical substance.Based on the observed condition, the stopcock was likely exposed to collodion remover and/or acetone.Root cause - the complaint was confirmed.The most probable cause of the reported leak was cracking of the stopcock body.Evidence observed on the device confirms that the stopcock came in contact with an incompatible chemical substance.It is likely that this chemical is the collodion remover used to remove the eeg electrodes from the patient¿s head.This is also supported by the report stating that the leak was observed at the ¿port closest to the head¿.The product ifu already addresses the risk of incompatible substances coming in contact with plastic components.As per ifu precautions, ¿contact with collodion remover, acetone and/or any other incompatible substances with product material may affect the integrity of the device, causing cracks and potential leaks on plastic components.¿ a causal relationship between the reported leak and the reported infection could not be established.Furthermore, it is unlikely that the infection manifested on the same day as the leak event, as bacterial growth and the development of infection generally require time.The ifu addresses infection-related risks associated with cerebrospinal fluid drainage systems and states: ¿the principal complications associated with cerebrospinal fluid drainage are infection, obstruction, or intracranial hypotension/ hypertension.The presence of a foreign body (i.E.The catheter system) may trigger infection or adverse reaction.Infection is a common and serious complication of a drainage system and is most frequently caused by skin contaminants.The incidence of these infections can be reduced by using aseptic technique.Risk of infection or other complications may be reduced by following hospital protocol for duration of use.Septicemia can result from infections anywhere in the body and may develop with few or no symptoms.¿ no further investigation is required based on the acceptability of the risk and the absence of adverse trends.This issue will continue to be monitored through the complaint trending process.At this time, the complaint is considered closed.
 
Additional Manufacturer Narrative
An investigation has been initiated based on the reported information.Upon completion of the investigation, a follow-up report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AccuDrain with Anti-Reflux Valve
Common Device Name
External CSF Drainage
Manufacturer (Section D)
Integra NeuroSciences PR
road 402 north, km 1.2
road 402 north, km 1.2
anasco PR 00610
Manufacturer (Section G)
Integra NeuroSciences PR
road 402 north, km 1.2
anasco PR 00610
Manufacturer Contact
vivian nelson
1100 campus drive
princeton, NJ 08540
+1(609)936-2319
MDR Report Key50161280
Report Number2648988-2026-00024
Device Sequence Number18785834
Product Code JXG
UDI-Device Identifier10381780023883
UDI-Public10381780023883
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K042825
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Type of Report Initial,Followup
Report Date (Section B) 09/23/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Operator of Device Health Professional
Device Catalogue NumberINS8401
Device Lot Number7639341
Date Returned to Manufacturer08/26/2026
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/18/2026
Supplement Date Received by Manufacturer09/03/2026
Initial Report FDA Received Date08/06/2026
Supplement Report FDA Received Date09/23/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/13/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age70 YR
Patient SexFemale
Patient RaceBlack Or African American
-
-